MariMed, Inc. (MRMD)
0.0666
-0.01
(-18.28%)
USD |
OTCM |
May 15, 16:00
MariMed EPS Diluted (Quarterly) : -0.0095 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.815 |
| Esperion Therapeutics, Inc. | -0.1002 |
| Aquestive Therapeutics, Inc. | -0.0657 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.767M |
| Revenue (Quarterly) | 39.48M |
| Total Expenses (Quarterly) | 43.27M |
| Enterprise Value | 114.81M |
| Gross Profit Margin (Quarterly) | 20.32% |
| Profit Margin (Quarterly) | -9.54% |
| Earnings Yield | -47.90% |
| Normalized Earnings Yield | -48.35 |